+10000000)+'&millis='+new Date().getTime()+'&zid=472&referrer='+encodeURIComponent(document.location)+')
New joint product development is being driven by an increased awareness of the need to treat joints without hurting the stomach--that is, without causing gastric ulcers. In June 2004, a product that delivers the strength of a non-steroidal anti-inflammatory drug (NSAID) in a topical cream formulation was approved by the federal Food and Drug Administration (FDA) for treating joint pain and inflammation in horses. Its name is Surpass Topical Anti-Inflammatory Cream. This new product and others for treating equine joints will be covered here.
Sunday, November 07, 2004+10000000)+'&millis='+new Date().getTime()+'&zid=473&referrer='+encodeURIComponent(document.location)+')
+10000000)+'&millis='+new Date().getTime()+'&zid=476&referrer='+encodeURIComponent(document.location)+')
+10000000)+'&millis='+new Date().getTime()+'&zid=441&referrer='+encodeURIComponent(document.location)+')
+10000000)+'&millis='+new Date().getTime()+'&zid=366&referrer='+encodeURIComponent(document.location)+')
+10000000)+'&millis='+new Date().getTime()+'&zid=466&referrer='+encodeURIComponent(document.location)+')
Copyright © 2012 Blood-Horse Publications. All rights reserved internationally.
+10000000)+'&millis='+new Date().getTime()+'&zid=601&referrer='+encodeURIComponent(document.location)+')